Steven Gillis - 17 Jun 2021 Form 4 Insider Report for Homology Medicines, Inc. (FIXX)

Role
Director
Signature
/s/ Bradford Smith, Attorney-in-Fact for Steven Gillis
Issuer symbol
FIXX
Transactions as of
17 Jun 2021
Transactions value $
$0
Form type
4
Filing time
22 Jun 2021, 17:35:20 UTC
Next filing
22 Jun 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FIXX Option (Right to Buy) Award $0 +18K $0.00 18K 17 Jun 2021 Common Stock 18K $7.26 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option shall vest and become exercisable on the earlier of June 17, 2022 or the day immediately prior to the date of the Issuer's next annual meeting of stockholders occurring after the date of grant, in either case subject to the Reporting Person continuing in service on the Board as a Non-Employee Director through such vesting date.